These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11414382)

  • 1. Ciprofloxacin: efficacy and indications.
    Finch RG
    J Chemother; 2000 Jan; 12 Suppl 1():5-7. PubMed ID: 11414382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
    Davis R; Markham A; Balfour JA
    Drugs; 1996 Jun; 51(6):1019-74. PubMed ID: 8736621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical results of parenterally administered new quinolones in humans.
    Lode H
    Rev Infect Dis; 1989; 11 Suppl 5():S996-1004. PubMed ID: 2672264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolones in gastrointestinal infections.
    Graninger W; Zedtwitz-Liebenstein K; Laferl H; Burgmann H
    Chemotherapy; 1996 Mar; 42 Suppl 1():43-53. PubMed ID: 8861534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
    Blondeau JM
    Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
    Patrick CC
    Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
    D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
    J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE; Herrington DA; Wade JC; Lazarus HM; Reed MD; Sinclair JW; Haverstock DC; Kowalsky SF; Hurd DD; Cushing DA; Harman CP; Donowitz GR
    Ann Intern Med; 2002 Jul; 137(2):77-87. PubMed ID: 12118962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
    Del Favero A; Menichetti F
    Eur J Cancer; 1993; 29A Suppl 1():S2-6. PubMed ID: 8427721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluoroquinolones--a new and important group of antimicrobial agents].
    Sander J
    Tidsskr Nor Laegeforen; 1992 Jan; 112(3):346-9. PubMed ID: 1553674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
    Bouza P; García Falcón T; Pérez Fontán M; Rodríguez-Carmona A; López Vázquez M; Tresancos C; Valdés F
    Adv Perit Dial; 1996; 12():185-8. PubMed ID: 8865898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
    Antabli BA; Bross P; Siegel RS; Small CD; Tabbara IA
    Int J Antimicrob Agents; 1999 Oct; 13(2):127-30. PubMed ID: 10595571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
    Fong IW
    Clin Invest Med; 1989 Feb; 12(1):44-9. PubMed ID: 2646054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
    Bayston KF; Want S; Cohen J
    Am J Med; 1989 Nov; 87(5A):269S-273S. PubMed ID: 2686428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.